{
    "id": 29540,
    "fullName": "PTPRT mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PTPRT mutant indicates an unspecified mutation in the PTPRT gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 11122,
        "geneSymbol": "PTPRT",
        "terms": [
            "PTPRT",
            "RPTPrho"
        ]
    },
    "variant": "mutant",
    "createDate": "03/08/2019",
    "updateDate": "03/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16319,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a clinical study, 38.9% (7/18) of metastatic colorectal cancer patients in a cohort who did not respond to Avastin (bevacizumab) therapy harbored deleterious mutations (defined by the study as truncations, splice site mutations, or variants in the COSMIC database) in PTPRT or PTPRD whereas no responders harbored deleterious mutations in these genes (PMID: 30200630).",
            "molecularProfile": {
                "id": 31583,
                "profileName": "PTPRT mutant"
            },
            "therapy": {
                "id": 667,
                "therapyName": "Bevacizumab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 14448,
                    "pubMedId": 30200630,
                    "title": "PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30200630"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31583,
            "profileName": "PTPRT mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}